Company / SG&A Expense
SI-BONE, Inc. SG&A Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$40.5M
FY2025
5-year range
$19.8M / $40.5M
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
#150 of 158
Health Care
What the data says
Among 158 Health Care companies, SI-BONE, Inc. is in the top 5% for sg&a expense. SG&A Expense has increased for 4 consecutive years, from $20M in FY2021 to $41M in FY2025.
Based on SEC 10-K filings.
$41M in FY2025 with a 5-year CAGR of +14.1%.
Increased from $31M to $41M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 158This company $40.5M Sector average $175.9B
▼
-100.0% below sector average
Key checks
Key Insights
- SI-BONE, Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +14.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 20.1% year-over-year.
- Ranks #150 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.5M | +20.1% |
| FY2024 | $33.8M | +8.6% |
| FY2023 | $31.1M | +23.9% |
| FY2022 | $25.1M | +26.6% |
| FY2021 | $19.8M | -5.6% |
| FY2020 | $21.0M | +66.0% |
| FY2019 | $12.6M | -3.2% |
| FY2018 | $13.1M | +0.0% |
| FY2017 | $13.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026